Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 453-456

  Khan, A S ^a   Polezhaev, F ^b   Vasiljeva, R ^b   Drinevsky, V ^b   Buffington, J ^b   Gary, H ^b   Sominina, A ^b   Keitel, W ^b   Regnery, H ^b   Lonskaya, N L ^b   Doroshenko, E ^b   Gavrilov, A ^b   Ivakhov, I ^b   Arden, N ^b   Schonberger, L B ^b   Couch, R ^b   Kendal, A ^b   Cox, N ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; PLACEBO;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; ERYTHEMA; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; USSR;

EID: 9044238066     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.453     Document Type: Article

References (13)

1. Zhadanov VM. Live influenza vaccines in USSR: development of studies and practical application. In: Kendal AP, Patriarca PA, eds. Options for the control of influenza. New York: Alan R Liss, 1986:193-206.
2. Kendal AP, Maassab HF, Alexandrova GI, Ghendon YZ. Development of cold-adapted recombinant live, attenuated influenza vaccines in the USA and USSR. Antiviral Res 1981;1:339-65.
3. Maassab HF, Shaw MW, Heilman CA. Live influenza virus vaccine. In: Plotkin S, Mortimer EA Jr, eds. Vaccine. Philadelphia: WB Saunders, 1994:781-801.
4. Wright PF, Johnson PR, Karzon DT. Clinical experience with live attenuated vaccines in children. In: Kendal AP, Patriarca PA, eds. Options for the control of influenza. New York: Alan R Liss, 1986:243-54.
5. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
6. Slepushkin AN, Patriarca PA, Obrosova-Serova NP, et al. Class-specific antibody responses in school children vaccinated with an A/Brazil/11/ 78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain. Vaccine 1988;6:25-8.
7. Committee on Standard Serologic Procedures in Influenza Studies. An agglutination-inhibition test proposed as a standard reference in influenza diagnostic studies. J Immunol 1950;65:347-53.
8. Ruben FL, Jackson GG. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity. J Infect Dis 1972;125:656-64.
9. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 1993;163:881-7.
10. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991;145:445-8.
11. Clements DA, Langdon ML, Bland CL, Walter EB. Influenza A vaccine decreases the incidence of otitis media in 6-30 month old day care children. Arch Pediatr Adolesc Med 1995;149:1113-7.
12. Piedra PA, Glezen WP. Influenza in children: epidemiology, immunity, and vaccines. Semin Pediatr Infect Dis 1991;2:140-6.
13. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25-44.